SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Viking Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of therapies for metabolic and endocrine disorders. The company was founded by Brian Lian and Michael A. Dinerman on September 24, 2012 and is headquartered in San Diego, CA.

Viking Therapeutics Inc

Positive VK2735 maintenance-study resultsshowing patients retained most of their weight loss on less-frequent injections, alongside encouraging efficacy and tolerabilitydrove a sharp rally and analyst optimism. Traders are celebrating the data and speculating about a partnership or buyout, while others warn about possible dilution and question whether the gains will hold.

IonQ, Inc. develops and manufactures quantum computers. The firm specializes in quantum computing and quantum information processing. The company was founded by Christopher Monroe and Jung Sang Kim in 2015 and is headquartered in College Park, MD.

IonQ Inc

IonQs reported real-time quantum error-correction decoder running on a standard CPU is the main focus, with bullish traders viewing it as progress toward scalable fault-tolerant systems. Skeptics caution that the demonstration does not prove the company has built a large-scale quantum computer, and debate whether the news can sustain the stocks gains.

Infleqtion, Inc. engages in delivering neutral atom solutions for quantum computing, networking, sensing, and security. Its products are categorized into computing, sensing, and cores. The company was founded on February 7, 2007, and is headquartered in Louisville, CO.

Infleqtion Inc. - Ordinary Shares - Class A

Infleqtion Inc.

Infleqtions integration of its error-correction software with NVIDIAs CUDA-Q Logical platform is drawing attention, with traders focused on the reported improvement in physical-qubit efficiency and its potential to advance fault-tolerant quantum computing. Bullish investors view it as meaningful technical progress, while others are frustrated that the stock has not consistently responded and point to volatile quantum-sector and broader market trading.

ImmunityBio, Inc. is a clinical stage immunotherapy company. It develops next generation therapies that drive immunogenic mechanisms for defeating cancers and infectious diseases. The company's immunotherapy platform activates both the innate and adaptive immune systems to create long term immunological memory. ImmunityBio was founded by Patrick Soon-Shiong in 2014 and is headquartered in San Diego, CA.

ImmunityBio Inc

A sharp, high-volume rally with no confirmed company announcement has focused attention on founder Patrick Soon-Shiongs tokenized-stock plans and speculation that IBRX could be included. Bullish traders say tokenization could constrain short selling and fuel a squeeze; others view it as hype, while separate speculation about a Turkey deal or Anktiva approval remains unconfirmed.

Hedera is a decentralized public network where developers can build secure, fair applications with near real-time consensus. The platform is owned and governed by a council of global innovators including Avery Dennison, Boeing, Deutsche Telekom, DLA Piper, FIS (WorldPay), Google, IBM, LG Electronics, Magalu, Nomura, Swirlds, Tata Communications, University College London (UCL), Wipro, and Zain Group.   The Hedera Consensus Service (HCS) acts as a trust layer for any application or permissioned network and allows for the creation of an immutable and verifiable log of messages. Application messages are submitted to the Hedera network for consensus, given a trusted timestamp, and fairly ordered. Use HCS to track assets across a supply chain, create auditable logs of events in an advertising platform, or even use it as a decentralized ordering service.

Hedera Hashgraph

HBARs sharp rebound toward the 10-cent level is driving attention, with traders pointing to improving chart momentum and hoping for a breakout. Others remain skeptical, calling the move another short-lived pump and citing overhead resistance; no specific catalyst is clearly established.

Microsoft Corp. engages in the development and support of software, services, devices, and solutions. It operates through the following segments: Productivity and Business Processes, Intelligent Cloud, and More Personal Computing. The Productivity and Business Processes segment is composed of products and services relating to productivity, communication, and information services such as Office Commercial, Office Consumer, LinkedIn, and Dynamics business solutions. The Intelligent Cloud segment consists of public, private, and hybrid server products and cloud services for businesses and developers, as well as enterprise and partner services. The More Personal Computing segment refers to products and services including Windows operating system, Windows cloud services, Surface, HoloLens, personal computer accessories, Xbox hardware, Xbox Cloud Gaming, Microsoft News, and Microsoft Edge. The company was founded by Paul Gardner Allen and William Henry Gates, III in 1975 and is headquartered in Redmond, WA.

Microsoft Corporation

Microsoft Corp

Analyst upgrades and bullish AI/Azure commentary are competing with Microsofts repeated difficulty clearing a key round-number level, leaving traders divided between dip-buying and short-term bearish calls. The community is also weighing AI spending and safety concerns against expectations for continued growth.

Omeros Corp. operates as a biopharmaceutical company, which engages in the research, discovery, development, and commercialization of small-molecule and protein therapeutics targeting immunologic diseases. It also offers orphan indications targeting inflammation, coagulopathies, and disorders of the central nervous system. The company was founded by Gregory A. Demopulos and Pamela Pierce Palmer on June 16, 1994 and is headquartered in Seattle, WA.

Omeros Corporation

Omeros Corp

Cantor Fitzgeralds upgrade, citing Yartemleas commercial momentum and greater sales potential, is the main catalyst behind OMERs sharp move. Traders are broadly bullish, though some debate whether the upgrade alone explains the volume and speculate about institutional buying or short covering.

Voyager Technologies, Inc. engages in the defense technology and space solutions. It operates through the following segments: Defense and Space Technologies, and Starlab Space Stations. The Defense and Space Technologies segment consists of innovative mission-critical solutions to protect dynamic and contested domains. The Starlab Space Stations segment consists of a commercial space station. The company was founded by Dylan Taylor and Matthew Kuta on August 15, 2019 and is headquartered in Denver, CO.

Voyager Technologies Inc. - Ordinary Shares - Class A

Voyagers proposed convertible senior notes offering is driving the discussion, with traders concerned about dilution, repeated fundraising and pressure on shareholders. Some see the selloff as a buying opportunity or believe the financing is priced in, while others criticize managements capital needs.

Royal Caribbean Group is a cruise company, which engages in the ownership and operation of the following global cruise brands: Royal Caribbean International, Celebrity Cruises, and Silversea Cruises. The firm also holds interest in TUI Cruises GmbH, which operates the German brands TUI Cruises and Hapag-Lloyd Cruises. The company was founded by Arne Wilhelmsen in 1968 and is headquartered in Miami, FL.

Royal Caribbean Group

Royal Caribbeans reported plan to acquire a controlling stake in Sandals Resorts is driving attention, with traders focused on the deals cost and how it may be financed. Some fear debt or share dilution and criticize the acquisition, while others argue Sandals could diversify the business and add profitable resort operations; the deal is discussed as not yet confirmed.

Xanadu Quantum Technologies Ltd. engages in the provision of quantum computing solutions for enterprise and government customers. The company was founded by Christian Weedbrook on October 2, 2025 and is headquartered in Toronto, Canada.

Xanadu Quantum Technologies Ltd. - Ordinary Shares - Class B (Sub Voting)

The 180-day lockup expiration, which traders say made a large block of early-holder shares eligible to trade, is the main focus and is being blamed for heavy selling and a sharp decline. The community is split between buying the weakness and expecting more pressure from the added share supply and potential dilution through the ATM program.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 
